About Empirica Therapeutics

About company

Empirica Therapeutics is a developer of therapeutic drugs designed to treat aggressive forms of cancer. The company is focused on the development of adoptive immunotherapies against the most aggressive and treatment-resistant forms of cancers, including glioblastoma (GBM) and brain metastasis (BM), creating better treatment opportunities for cancers with substantial unmet need.